AdaptHealth (AHCO) Price to Sales (2019 - 2026)

AdaptHealth has reported Price to Sales for 8 years, with the latest figure at 1.92 in Q2 2026.

• On a quarterly basis, Price to Sales fell 1.13% year-over-year to 1.92 in Q2 2026; TTM through Jun 2026 was 0.44, a 6.93% increase from a year earlier, with the FY2025 full-year figure at 0.42, up 5.8% from the prior year.
• Price to Sales was 1.92 for Q2 2026 at AdaptHealth, down from 1.97 in the prior quarter.
• The five-year high for Price to Sales was 3.34 in Q3 2022, with the low at 1.13 in Q4 2023.
• Average Price to Sales over 5 years is 2.1, with a median of 1.93 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Price to Sales plunged 69.11% in 2022, then jumped 32.77% in 2024.
• Over 5 years, Price to Sales stood at 3.31 in 2022, then slumped by 65.98% to 1.13 in 2023, then surged by 32.77% to 1.5 in 2024, then rose by 6.57% to 1.59 in 2025, then grew by 20.35% to 1.92 in 2026.
• The last three Price to Sales figures came in at 1.92 (Q2 2026), 1.97 (Q1 2026), and 1.59 (Q4 2025), per Business Quant data.